Abstrait
L’âge est un facteur de risque majeur du cancer du sein. Exceptionnel avant 25 ans, très rare avant 30 ans, son incidence augmente de façon exponentielle jusqu’à l’âge de 45-50 ans où elle ralentit pour continuer d’augmenter ensuite de manière sensible surtout dans les pays à risque élevé. L’incidence maximale est observée entre 60 et 69 ans, supérieure à 320/100 000 (23). Les taux d’incidence diminuent légérement ensuite pour atteindre 245/100 000 à 85 ans.
Preview
Unable to display preview. Download preview PDF.
References
Anderson WF, Matsuno R (2006) Breast cancer heterogeneity: a mixture of at least two main types. J Natl Cancer Inst 19; 98: 948–951
Anderson WF, Pfeiffer RM, Dores GM, Sherman ME (2006) Comparison of age distribution patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomarkers Prev 15: 1899–1905
Anderson WF, Jatoi I, Devesa SS (2005) Distinct breast cancer incidence and prognostic patterns in the NCI’s SEER program: suggesting a possible link between etiology and outcome. Breast Cancer Res Treat 90: 127–137
Anderson WF, Chatterjee N, Ershler WB, Brawley OW (2002) Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database. Breast Cancer Res Treat 76: 27–36
Armitage P, Doll R (1957) A two-stage theory of carcinogenesis in relation to the age distribution of human cancer. Br J Cancer 11: 161–169
Bianchini F, Kaaks R, Vainio H (2002) Overweight, obesity, and cancer risk. Lancet Oncol 3: 565–574. Comment in: Lancet Oncol 3: 517
Bossard N, Veiten M, Remontet L et al. (2007) Survival of cancer patients in France: A population-based study from The Association of the French Cancer Registries (FRANCIM). Eur J Cancer 43: 149–160
Bouchardy C, Rapiti E, Fioretta G et al. (2003) Undertreatment strongly decreases prognosis of breast cancer in elderly women. J Clin Oncol 21: 3580–3587
Clemmesen J. Carcinoma of the breast (1948) Br J Radiol 21: 583–590
Diab SG, Elledge RM, Clark GM (2000) Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 92: 550–556
Durieux A (2005) Cancer du sein opéré d’emblée chez la femme de moins de 40 ans: facteurs pronostiques de la rechute métastatique. Rapport de Thèse. Bordeaux, le 11 octobre 2005
Eisinger F, Ronda I, Puig B, Camerlo J, Giovannini MH, Bardou VJ (2006) Breast cancer guidelines-Physicians’ intentions and behaviors. Int J Cancer 120: 1136–1140
Feigelson HS, Jonas CR, Teras LR et al. (2004) Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev 13: 220–224
Goldhirsch A, Gelber RD, Yothers G et al. (2001) Adjuvant therapy for very young women with breast cancer: need for tailored treatments. J Natl Cancer Inst Monogr 44–51
Grann VR, Troxel AB, Zojwalla NJ et al. (2005) Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma. Cancer 103: 2241–2251
Grosclaude P, Colonna M, Hedelin G et al. (2001) Survival of women with breast cancer in france: variation with age, stage and treatment. Breast Cancer Res Treat 70: 137–143
Hill C, Doyon F (2006) The frequency of cancer in France in year 2002, and trends since 1968. Bull Cancer 93: 7–11
Hill C, Doyon F (2004) Frequency of cancer in France: 2004 update. Bull Cancer 91: 9–14
Hill C, Doyon F (2003) Frequency of cancer in France. Bull Cancer 90: 207–213
Magnusson CM, Roddam AW, Pike MC et al. (2005) Body fatness and physical activity at young ages and the risk of breast cancer in premenopausal women. Br J Cancer 93: 817–824
Pierga JY, Girre V, Laurence V et al. (2004) Institut Curie Breast Cancer Study Group. Characteristics and outcome of 1755 operable breast cancers in women over 70 years of age. Breast 13: 369–375
Pike MC, Spicer DV, Dahmoush L, Press MF (1993) Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 15: 17–35
Remontet L, Esteve J, Bouvier AM et al. (2003) Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Santé Publique 51: 3–30
Sant M, Francisci S, Capocaccia R et al. (2006) Time trends of breast cancer survival in Europe in relation to incidence and mortality. Int J Cancer 119: 2417–2422
Schairer C, Mink PJ, Carroll L, Devesa SS (2004) Probabilities of death from breast cancer and other causes among female breast cancer patients. J Natl Cancer Inst 96: 1311–1321
Singh R, Hellman S, Heimann R (2004) The natural history of breast carcinoma in the elderly: implications for screening and treatment. Cancer 100: 1807–1813
Smigal C, Jemal A, Ward E et al. (2006) Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin. 56: 168–183
Trétarre B, Guizard AV, Fontaine D, les membres du réseau Francim et le CépiDc-Inserm (2004) Cancer du sein: incidence et mortalité, France 2000. Bull Epidemiol Hebdo 44: 209–210
Yasui Y, Potter JD (1999) The shape of age-incidence curves of female breast cancer by hormone-receptor status. Cancer Causes Control 10: 431–437
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag France, Paris
About this paper
Cite this paper
Debled, M., Durieux, A., Monnereau, A., Mauriac, L. (2007). Risque et âge. In: Cancer du sein. Springer, Paris. https://doi.org/10.1007/978-2-287-71478-8_3
Download citation
DOI: https://doi.org/10.1007/978-2-287-71478-8_3
Publisher Name: Springer, Paris
Print ISBN: 978-2-287-71477-1
Online ISBN: 978-2-287-71478-8